Is Colgate-Palmolive (India) Limited (COLPAL.NS) overvalued or undervalued?
Updated Sep 3, 2026 · auto-modeled from live data · educational, not advice
At a recent price of ₹1,852, Colgate-Palmolive (India) Limited (COLPAL.NS) trades 29% above TickerWorth's blended fair value of ₹1,307 per share — a discounted-cash-flow model cross-checked against peer multiples and asset value — meaning the market currently prices COLPAL.NS overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -29.4% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
One of the lenses behind that blended figure is a discounted-cash-flow model, which on its own values COLPAL.NS at about ₹1,421 per share. The rest of this page walks through that DCF — its assumptions, reverse-DCF and discount-rate sensitivity — because it is the auditable anchor of the blend.
The valuation discounts Colgate-Palmolive (India) Limited's projected free cash flows at a weighted-average cost of capital (WACC) of 7.3%, with a long-run terminal growth rate of 2.5%. About 81% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 14.6% annual revenue growth for COLPAL.NS. Our base case instead assumes about 7.9% average growth over the forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, COLPAL.NS's modeled DCF value ranges from about ₹973.29 to ₹2,857 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Colgate-Palmolive (India) Limited would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of COLPAL.NS's intrinsic value. Figures update as new filings and prices come in.
The assumptions behind COLPAL.NS's DCF
| Input | Value | Source |
|---|---|---|
| Base-year revenue | ₹62,042,800,000 | Live feed — totalRevenue (TTM) |
| Base EBIT margin | 27.7% | Computed — trailing operatingMargins, held roughly flat |
| Forecast revenue growth | 12% → 10% → 8% → 6% → 4% | Assumption — TickerWorth's 5-year explicit forecast |
| Risk-free rate | 4.8% | Live feed — US 10-year Treasury yield (^TNX) |
| Beta | 0.52 | Live feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) |
| Terminal growth | 2.5% | Assumption — TickerWorth house default 2.5%, held below WACC |
| Diluted shares | 272M | Live feed — sharesOutstanding |
| Market price | ₹1,852 | Delayed quote · as of 2026-09-03 08:09 UTC |
Auto-modeled from live market data — this is NOT a hand-researched model. Every growth, margin and capital assumption is an algorithmic ESTIMATE, cached and refreshed periodically.
Explore more
Most undervalued stocks (per our valuation) · All valued stocks · Interactive COLPAL.NS valuation & downloadable modelEducational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is an educational DCF tool, not a licensed investment adviser. Figures are estimates derived from public filings and market data and can be wrong.